Phase 1, Randomized, Double-Blind, Pharmacokinetic and Glucodynamic 6-Way Crossover Study of SC Administered Insulin Lispro With Recombinant Human Hyaluronidase (rHuPH20) and Regular Human Insulin With Recombinant Human Hyaluronidase (rHuPH20) Compared to Insulin Lispro Alone in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 12 Sep 2014
At a glance
- Drugs Hyaluronidase; Insulin; Insulin lispro
- Indications Diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Halozyme Therapeutics
- 07 Nov 2009 Study results were presented the Diabetes Technology Society meeting, according to a Halozyme media release.
- 06 Oct 2009 Actual end date (Aug 2009) added as reported by ClinicalTrials.gov.
- 06 Oct 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.